Imagine spending over a year undergoing brutal chemotherapy and radiation for a disease you never actually had. That is the devastating reality Tanya Smith faced. Her story highlights a terrifying gap in diagnostic accuracy and sets a massive legal precedent for medical malpractice claims across the country.
Doctors treated Smith for metastatic breast cancer for thirteen months before discovering she actually suffered from an entirely different, highly aggressive condition. Following her tragic death in January 2019, her family fought through a maze of legal hurdles. Recently, the Pennsylvania Supreme Court ruled that their malpractice lawsuit deserves to go in front of a jury. This case changes how courts look at delayed diagnoses and medical negligence. You might also find this connected article useful: How Surgical Robots Are Quietly Shrinking Gynecology Waiting Lists.
How a Routine Lump Turned Into a Thirteen Month Nightmare
The ordeal began in March 2017. Smith visited an oncological surgeon at WellSpan York Hospital after discovering an enlarged lymph node in her armpit while dealing with shoulder pain. A biopsy followed. Pathologist Dr. John Wright issued a report stating the findings were compatible with metastatic breast cancer, implying a primary tumor in the breast had spread.
Yet, red flags popped up almost immediately. Follow-up imaging tests including a CT scan, a PET scan, a mammogram, and an ultrasound failed to find any primary tumor in the breast tissue. Both the CT and PET scans explicitly floated lymphoma as a potential alternative diagnosis. As highlighted in detailed articles by Psychology Today, the implications are significant.
Despite those conflicting reports, oncologist Dr. Annie Kannarkatt at Cancer Care Associates of York initiated aggressive breast cancer treatments on March 21, 2017. Smith endured punishing rounds of chemotherapy and radiation. While targeted radiation shrank tumors locally, her overall health deteriorated. By November 2017, a new PET scan revealed the cancer had spread extensively throughout her body.
The Truth Emerges Too Late
The real diagnosis finally came to light during surgery to remove Smith's gallbladder in March 2018. Pathologists re-examined the tissue and identified ALK-positive large B-cell lymphoma. This represents an extremely rare and aggressive cancer type.
When medical teams retroactively reviewed the original March 2017 tissue samples, they matched the later findings. Smith had lymphoma from day one.
She transferred to the Milton S. Hershey Medical Center under oncologist Dr. Seema Naik. They attempted lymphoma-specific chemotherapy and salvage treatments, eventually clearing enough cancer to perform a stem cell transplant. The transplant failed. The cancer returned, and Smith passed away on January 6, 2019.
The Legal Battle and the High Court Ruling
Before her passing, Smith and her husband Marvin filed a lawsuit against Dr. Kannarkatt and Cancer Care Associates. They argued that the medical team ignored clear imaging contradictions, failed to consult pathologists properly, and administered the wrong treatment protocol for over a year.
The legal journey was brutal. A 2021 jury trial ended in a mistrial due to a deadlocked jury. During a second trial in April 2022, the judge dismissed the case outright, claiming the family failed to provide sufficient evidence that the delay directly caused harm.
An appeals court overturned that dismissal, leading the defense to appeal to the Pennsylvania Supreme Court. On October 29, the state's highest court handed down a definitive ruling. The justices agreed that the family presented enough expert testimony to let a jury decide whether the diagnostic failure increased Smith's risk of harm.
Medical experts during the trials testified candidly about the consequences. Dr. Gerald Goldklang pointed out that oncologists must weigh pathology reports against actual clinical and imaging findings. When scans show zero evidence of breast cancer, doctors must question the primary diagnosis. Furthermore, Dr. Robert Soiffer explained that undertreating aggressive lymphoma allows the disease to mutate and develop resistance to standard therapies, directly narrowing a patient's window for survival.
What This Means for Patients and Medical Liability
This legal showdown addresses a central frustration in medical malpractice law. Historically, defense teams often argued that plaintiffs must prove absolute certainty—that a timely diagnosis would have guaranteed a cure. In aggressive cancers, proving a 100 percent survival rate under ideal conditions is virtually impossible.
The Pennsylvania Supreme Court's stance cuts through that defense tactic. The court affirmed that patients do not need to prove absolute survival certainty. Showing that negligence or delayed investigation substantially increased the risk of harm or robbed the patient of a meaningful fighting chance is enough to warrant a jury trial.
If you or a loved one face a complex or rare diagnosis, this case underscores the vital importance of seeking second opinions when imaging results and pathology reports clash. Questioning your care team isn't being difficult. It can save your life.
Review your medical records, demand clear explanations when scans don't match biopsy findings, and don't hesitate to consult independent specialists at academic medical centers. Accountability starts with informed vigilance.
